fertility-health
Thyroid Disorders and Fertility: How Hypothyroidism and Hyperthyroidism Affect Conception
Dr. Carolina Gallardo
Male Factor Infertility
Male factor contributes to 40–50% of all infertility cases — yet it remains underdiagnosed and undertreated despite having excellent treatment options including ICSI.
Contributes to 40–50% of all infertility cases; sole cause in ~20% of couples
Semen analysis is the cornerstone diagnostic test — WHO 2021 reference values define normal parametersAzoospermia (no sperm in ejaculate) affects 1% of all men and 10–15% of infertile menVaricocele is the most common correctable cause, present in ~40% of infertile menY-chromosome microdeletions are found in 5–10% of men with severe oligozoospermia or azoospermia (Reijo et al., Nat Genet 1995)ICSI (intracytoplasmic sperm injection) achieves fertilization rates comparable to standard IVF regardless of sperm concentration
Find Clinics That Specialize in Male FactorHow Male Factor Affects Fertility
Male infertility is defined by abnormalities in one or more semen parameters: sperm count (oligozoospermia: <16 million/mL per WHO 2021 reference values), motility (asthenozoospermia: <42% total motility), morphology (teratozoospermia: <4% normal forms by Kruger strict criteria), or sperm DNA fragmentation. When all three are affected simultaneously, the condition is termed oligoasthenoteratozoospermia (OAT). Complete absence of sperm is termed azoospermia, which may be obstructive (OA — sperm production is normal but the ductal system is blocked, often due to vasectomy, congenital bilateral absence of the vas deferens, or prior infection) or non-obstructive (NOA — the testes fail to produce adequate sperm due to testicular failure, hormonal deficiency, or genetic causes).
Causes of male factor infertility span a wide spectrum. Varicocele (dilated testicular veins causing elevated scrotal temperature) is found in approximately 40% of infertile men and is the most common surgically correctable etiology. Hormonal causes include hypogonadotropic hypogonadism (low FSH/LH from the pituitary, preventing testosterone and sperm production) and hyperprolactinemia. Genetic causes include Y-chromosome microdeletions in the AZFa, AZFb, or AZFc regions, which together affect 5–10% of men with severe oligozoospermia or NOA, and Klinefelter syndrome (47,XXY), the most common genetic cause of male infertility, present in ~1 in 660 men and accounting for 10% of NOA cases. Lifestyle factors — obesity, smoking, anabolic steroid use, excessive heat exposure, and heavy alcohol use — significantly impair sperm production and DNA integrity.
Sperm DNA fragmentation (SDF) — double-strand breaks in sperm chromatin — is increasingly recognized as a clinically important parameter not captured by standard semen analysis. Elevated SDF (>25–30% by TUNEL or SCSA assay) is associated with reduced natural conception rates, higher miscarriage rates, and poorer IVF/ICSI embryo development even with normal count and motility (Zini et al., J Urol 2008; Zhao et al., J Assist Reprod Genet 2014). Testing for SDF is particularly relevant in unexplained infertility or recurrent pregnancy loss with normal standard semen analysis.
Treatment Options
Treatment is individualized based on age, severity, duration of infertility, and partner factors. Work with your reproductive endocrinologist to determine the right sequence for your specific situation.
First-line treatment
Lifestyle Modification
Spermatogenesis takes approximately 74 days (2–3 months), so lifestyle improvements take at least one cycle to manifest in semen parameters. Smoking cessation improves sperm motility and reduces DNA fragmentation. Weight loss in obese men (BMI >30) normalizes testosterone levels and sperm parameters. Avoiding anabolic steroids, hot tubs/saunas, and tight-fitting underwear are evidence-supported recommendations. Antioxidant supplementation (vitamin C, vitamin E, CoQ10) has modest supportive evidence from randomized trials (Showell et al., Cochrane 2020).
First-line treatment
Varicocelectomy
Surgical repair of varicocele (microsurgical subinguinal approach is preferred) significantly improves sperm parameters in appropriately selected patients — mean increases of 12 million sperm/mL and improved motility have been reported (Baazeem et al., Eur Urol 2011). A meta-analysis of RCTs demonstrated improved spontaneous pregnancy rates (Marmar et al., Fertil Steril 2007). Varicocelectomy is recommended when a palpable varicocele coexists with abnormal semen analysis and no female factor is identified. Allow 3–6 months post-surgery for semen parameter improvement.
Typical success rate
30–40% spontaneous pregnancy rate within 1–2 years in appropriately selected couples
Hormonal Treatment
Hypogonadotropic hypogonadism (low FSH, low LH, low testosterone) is treated with exogenous gonadotropins (FSH + hCG/LH) rather than testosterone replacement, which paradoxically suppresses sperm production. Treatment with FSH + hCG for 12–18 months can restore spermatogenesis in >80% of men with this diagnosis (Liu et al., Hum Reprod Update 2009). Clomiphene citrate off-label can raise endogenous FSH/LH in men with idiopathic low testosterone and oligozoospermia, though the evidence base is modest.
Typical success rate
>80% spermatogenesis restoration in hypogonadotropic hypogonadism with FSH/hCG therapy
IUI (Intrauterine Insemination)
IUI places washed, concentrated sperm directly into the uterus, bypassing the cervical barrier. It is appropriate for mild male factor (total motile sperm count >5 million post-wash) with patent tubes and normal female evaluation. Per-cycle success rates are modest (8–15%) but cumulative rates over 3–6 cycles are clinically meaningful. For total motile count below 5 million, IVF with ICSI is preferred over IUI due to substantially lower pregnancy rates (Van Voorhis et al., NEJM 1992).
Typical success rate
8–15% per cycle for mild MFI; cumulative 30–40% over 3–6 cycles
IVF with ICSI (Intracytoplasmic Sperm Injection)
ICSI involves injection of a single selected sperm directly into each mature oocyte, virtually eliminating sperm count and motility as barriers to fertilization. Fertilization rates of 60–80% per injected oocyte are consistently achieved regardless of sperm concentration, provided at least some motile sperm are present. ICSI is standard for moderate-to-severe oligozoospermia (<5 million/mL), severe asthenozoospermia, high DNA fragmentation, or prior fertilization failure with conventional IVF. SART 2022 data shows live birth rates per transfer for IVF-ICSI are equivalent to standard IVF when adjusted for age and diagnosis.
Typical success rate
40–55% live birth rate per embryo transfer for couples under 35 (SART 2022 data)
Surgical Sperm Retrieval (TESA/PESA/Micro-TESE)
For men with azoospermia, sperm may be retrieved surgically. Percutaneous epididymal sperm aspiration (PESA) or microsurgical epididymal sperm aspiration (MESA) is used for obstructive azoospermia — sperm retrieval rates exceed 90%. Testicular sperm extraction (TESE) or microdissection TESE (micro-TESE) is used for non-obstructive azoospermia; micro-TESE by an experienced surgeon achieves sperm retrieval in 40–60% of NOA cases (Schlegel, Hum Reprod 1999). Retrieved sperm are used with ICSI.
Typical success rate
Obstructive AZ: >90% sperm retrieval; NOA with micro-TESE: 40–60% retrieval; ICSI success rates apply if sperm retrieved
What Patients with Male Factor Can Expect
Male factor infertility treatment outcomes depend heavily on the severity of the abnormality, whether a correctable cause is identified, and the partner's age and fertility status. ICSI has transformed severe male factor from a condition requiring donor sperm to one where biological paternity is achievable in the majority of cases. Even in non-obstructive azoospermia, micro-TESE by a skilled urologist retrieves sperm in approximately half of men.
| Treatment | Typical Success Range |
|---|---|
| Lifestyle modification only (mild MFI) | Modest improvement in parameters; variable pregnancy rates |
| Varicocelectomy (palpable varicocele + abnormal SA) | 30–40% spontaneous pregnancy within 1–2 years |
| IUI (mild MFI, TMC >5M post-wash) | 8–15% per cycle; ~35% cumulative over 4–6 cycles |
| IVF + ICSI (moderate-severe MFI) | 40–55% live birth per transfer, age < 35 female partner |
| PESA/MESA + ICSI (obstructive azoospermia) | >90% sperm retrieval; ICSI live birth rates apply |
| Micro-TESE + ICSI (non-obstructive azoospermia) | 40–60% sperm retrieval; ICSI live birth rates if retrieved |
Individual outcomes vary significantly based on age, ovarian reserve, partner factors, and clinic expertise. These figures are based on published research (ASRM, SART, Cochrane Reviews) and national averages — they are not guarantees. Ask your clinic for their own reported outcomes for your specific diagnosis and age group.
Questions to Ask Your Reproductive Endocrinologist
Bring this list to your first consultation to make the most of your appointment.
- 1
What specific parameters in my semen analysis are abnormal, and by how much?
- 2
Should I have a urological evaluation for varicocele or other correctable causes?
- 3
Do you recommend sperm DNA fragmentation testing given my results?
- 4
Should I have hormonal testing (FSH, LH, testosterone, prolactin) and genetic testing (karyotype, Y-deletion)?
- 5
Given my sperm count, do you recommend IUI or should we go directly to IVF with ICSI?
- 6
If I have azoospermia, what type is it — obstructive or non-obstructive — and what are my options for sperm retrieval?
- 7
What lifestyle changes (smoking cessation, weight loss, heat avoidance) would you specifically recommend?
- 8
If we pursue ICSI, what fertilization and live birth rates do you achieve for couples with our profile?
When to See a Specialist
Couples where the male partner has a known semen analysis abnormality, prior testicular injury, surgery, or infection, or who have been trying to conceive for 6–12 months without success should see both a reproductive endocrinologist and a reproductive urologist. Male factor evaluation should occur simultaneously with female evaluation — not sequentially — to avoid diagnostic delay.
Ready to Find a Clinic That Specializes in Male Factor?
Look for clinics with reproductive endocrinologists (REs) who have documented experience treating Male Factor. Ask about their specific outcomes for your diagnosis and age group during your first consultation — outcomes vary significantly by clinic.
Select your state to browse fertility clinics near you:
Related Articles
IVF
Beta hCG After IVF: What Your First Result Means
Your first beta hCG result after IVF is one of the most nerve-wracking numbers in the entire process. This guide explains what it means, what doubling times to expect, how to interpret a borderline result, and what comes next.
Dr. Hannah Ní Bhriain Russell
IVF
OHSS After IVF: Symptoms, Classification, Prevention & Treatment
Ovarian hyperstimulation syndrome is the most serious complication of IVF stimulation. This guide covers who is at risk, how severity is graded, evidence-based prevention strategies, and what to do if symptoms develop.
Dr. Hannah Ní Bhriain Russell
Fertility Treatment
Adenomyosis and Fertility — IVF Outcomes & Treatment
Adenomyosis — endometrial tissue invading the uterine muscle — impairs implantation and raises miscarriage risk. This guide covers MRI diagnosis, GnRH agonist pretreatment, freeze-all IVF strategy, and realistic success rate expectations.
Dr. Hannah Ní Bhriain Russell